AQP4-IgG-Seropositive Patient Who Silently Carried Anti-NMDAR Antibodies Developed Encephalitis During A Relapse
The association of autoimmune diseases is relatively common. Comorbidity anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis and Neuromyelitis Optica Spectrum Disorder (NMOSD) is an unusual and rare overlapping syndrome. We report the case of an AQP4-IgG-seropositive NMOSD patient who developed anti-NMDAR encephalitis during corticosteroid treatment for a relapse of Longitudinal Extensive Transverse Myelitis (LETM), with the presence of anti-NMDAR antibodies in the serum two years earlier. The patient showed significant improvement in both clinical syndromes with a good response to steroid and immunosuppressive therapy. Conclusion Early diagnosis and treatment of overlapping autoimmune syndromes, such as AQP4+IgG seropositive NMOSD with anti-NMDAR encephalitis, are key factors for ensuring early and better recovery outcomes.
Authors
- Andrés Villa (ORCID: https://orcid.org/0000-0003-4344-1482)
- Graciela Ramos
- Analisa Manín (ORCID: https://orcid.org/0000-0002-7940-0052)
- Carla Seimandi
- Ana Mariel Finkelsteyn
Publication Details
- Journal
- Frontiers in Medical Case Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.47746/fmcr.2025.6101
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00